Authors: PRINSSEN HM MOLTHOFF CFM VERHEIJEN RHM BROADHEAD TJ KENEMANS P ROOS JC DAVIES Q VANHOF AC FRIER M DENHOLLANDER W WILHELM AJ BAKER TS SOPWITH M SYMONDS EM PERKINS AC

Citation: Hm. Prinssen et al., BIODISTRIBUTION OF IN-111-LABELED ENGINEERED HUMAN-ANTIBODY CTM01 (HCTM01) IN OVARIAN-CANCER PATIENTS - INFLUENCE OF PRIOR ADMINISTRATION OF UNLABELED HCTM01, Cancer immunology and immunotherapy, 47(1), 1998, pp. 39-46

Authors: MOLTHOFF CFM PRINSSEN HM KENEMANS P VANHOF AC DENHOLLANDER W VERHEIJEN RHM

Citation: Cfm. Molthoff et al., ESCALATING PROTEIN DOSES OF CHIMERIC MONOCLONAL-ANTIBODY MOV18 IMMUNOGLOBULIN-G IN OVARIAN-CARCINOMA PATIENTS - A PHASE-I STUDY, Cancer, 80(12), 1997, pp. 2712-2720

Authors: VANHOF AC MOLTHOFF CFM DAVIES Q PERKINS AC VERHEIJEN RHM KENEMANS P DENHOLLANDER W WILHELM AJ BAKER TS SOPWITH M FRIER M SYMONDS EM ROOS JC

Citation: Ac. Vanhof et al., BIODISTRIBUTION OF (111)INDIUM-LABELED ENGINEERED HUMAN-ANTIBODY CTMO1 IN OVARIAN-CANCER PATIENTS - INFLUENCE OF PROTEIN DOSE, Cancer research, 56(22), 1996, pp. 5179-5185